← SynDRA
WH-4023
SynDRA canonical compound SYN0061321 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | LCK | SRC |
| Mechanism of action | SRC inhibitor |
All known targets
Mechanisms of action (all sources)
- LCK INHIBITOR
- SRC inhibitor
Cross-references
Synonyms
- DUAL LCK/SRC INHIBITOR
- GTPL8068
- KIN001-112
- KIN112
- WH-4-023
- 2,6-dimethylphenyl (2,4-dimethoxyphenyl)(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)carbamate
- 2,6-dimethylphenyl N-(2,4-dimethoxyphenyl)-N-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)carbamate
- SCHEMBL5755186
- CHEMBL213100
- CHEBI:94644
- 2-aminopyrimidine carbamate, 28
- KS-00001CWM
- BDBM17729
- AOB6574
- MolPort-035-789-690
- HMS3653D15
- C32H36N6O4
- EX-A1078
- BCP10090
- s7565
- ZINC14965418
- 2801AH
- AKOS025142111
- CS-3292
- NCGC00346959-01
- RefChem:445740
- MFCD28138072
- HMSL10038
- Dual LCK/SRC inhibitor
- orb1307398
- SCHEMBL29352883
- KIN-112
- GLXC-05603
- HMS3265G11
- HMS3750E09
- CCG-270086
- NCGC00346959-07
- NCGC00346959-08
- NCGC00346959-09
Look up WH-4023 in the interactive SynDRA portal →